Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
J.C. Yang
Observed names:
J. C. Yang,
J. Yang,
Jen Yang
Institutions:
National Cheng Kung University Hospital,
National Cheng Kung University
Observed institutions:
Gilead Sciences (United States),
National Cheng Kung University Hospital,
National Cheng Kung University
ORCID:
0000-0002-7165-2140
Observed ORCID:
0000-0002-7165-2140
OpenAlex ID:
A5001405064
O005 : Retreatment of patients who failed 8 or 12 weeks of ledipasvir/sofosbuvir-based regimens with ledipasvir/sofosbuvir for 24 weeks
2015
·
E. Lawitz
, S. Flamm
, et al.
·
Journal of Hepatology
·
137
GS‐9857 in patients with chronic hepatitis C virus genotype 1–4 infection: a randomized, double‐blind, dose‐ranging phase 1 study
2016
·
M. Rodriguez‐Torres
, S. Glass
, et al.
·
Journal of Viral Hepatitis
·
66
PDF
Sofosbuvir plus ribavirin for the treatment of patients with chronic genotype 1 or 6 hepatitis C virus infection in Hong Kong
2015
·
C. L. Lai
, V. W.‐S. Wong
, et al.
·
Alimentary Pharmacology & Therapeutics
·
31
Use of ChatGPT on Taiwan’s Examination for Medical Doctors
2023
·
Yung-Shuo Kao
, Wei-Kai Chuang
, et al.
·
Annals of Biomedical Engineering
·
30
Deep learning-based auto-segmentation of lung tumor PET/CT scans: a systematic review
2022
·
Yung-Shuo Kao
, Jen Yang
·
Clinical and Translational Imaging
·
28
Cardiac Events and Survival in Patients With EGFR-Mutant Non–Small Cell Lung Cancer Treated With Osimertinib
2024
·
Chien-Yu Lin
, Wei-Ting Chang
, et al.
·
JAMA Network Open
·
23
Community‐based real‐world treatment outcomes of sofosbuvir/ledipasvir in Asians with chronic hepatitis C virus genotype 6 in the United States
2016
·
R. J. Wong
, M. T. Nguyen
, et al.
·
Journal of Viral Hepatitis
·
17
PDF
High Efficacy of Sofosbuvir/Velpatasvir Plus GS-9857 for 12 Weeks in Treatment-Experienced Genotype 1-6 HCV-Infected Patients, Including Those Previously Treated with Direct-Acting Antivirals
2016
·
E. Lawitz
, K. Kowdley
, et al.
·
Journal of Hepatology
·
12
P0861 : Evaluation of the pan-genotypic HCV NS3/4A protease inhibitor GS-9857 in healthy volunteers
2015
·
B. Kirby
, J. Yang
, et al.
·
Journal of Hepatology
·
11
Increased Cardiovascular Risk With Lorlatinib in Patients With ALK‐Mutated Lung Cancer: A Real‐World Comparative Study
2025
·
Chien‐Yu Lin
, Po‐Lan Su
, et al.
·
Journal of the American Heart Association
·
5
A systematic review for using deep learning in bone scan classification
2023
·
Yung-Shuo Kao
, Chun-Pang Huang
, et al.
·
Clinical and Translational Imaging
·
5
O109 All Oral Fixed-dose Combination Sofosbuvir/ledipasvir With or Without Ribavirin for 12 or 24 Weeks in Treatment-experienced Genotype 1 Hcv-infected Patients: the Phase 3 Ion-2 Study
2014
·
N. Afdhal
, R.K. Reddy
, et al.
·
Journal of Hepatology
·
5
Does Botulinum Toxin Injection Exacerbate Sarcopenia and Bone Mass in Individuals With Cerebral Palsy?
2023
·
Yu-Chi Su
, Meng-Che Tsai
, et al.
·
Pediatric Neurology
·
4
P0809 : 98% SVR12 in Korean And Taiwanese patients with chronic genotype 2 HCV infection receiving 12 weeks of sofosbuvir plus ribavirin: Results from an international, multicenter phase 3 study
2015
·
J.-H. Kao
, S.-H. Ahn
, et al.
·
Journal of Hepatology
·
4
Short Duration Treatment with Sofosbuvir/Velpatasvir plus GS-9857 in Treatment-Naive Genotype 1-6 HCV-Infected Patients with or without Cirrhosis
2016
·
E.J. Gane
, M. Nguyen
, et al.
·
Journal of Hepatology
·
3
P1353 : A single tablet regimen of ledipasvir/sofosbuvir for 12 weeks in HCV genotype 1 or 4 infected patients with HIV-1 co-infection : The phase 3 ION-4 study
2015
·
C. Cooper
, S. Naggie
, et al.
·
Journal of Hepatology
·
3
P0901 : The pan-genotypic NS3/4A protease inhibitor GS-9857 demonstrates potent antiviral activity in patients infected with HCV genotype 1, 2, 3 or 4 in a 3-day monotherapy study
2015
·
M. Rodriguez-Torres
, S. Glass
, et al.
·
Journal of Hepatology
·
3
Esophageal cancer localization by sagittal computed tomography images and endoscopic measurement
2024
·
Jen Yang
, Wei‐Lun Chang
, et al.
·
The Kaohsiung Journal of Medical Sciences
·
1
P0857 : 98% SVR12 in Korean and Taiwanese patients with chronic genotype 1 HCV infection receiving 12 weeks of ledipasvir/sofosbuvir: Results from an international, multicenter phase 3 study
2015
·
Y.-S. Lim
, W.-L. Chuang
, et al.
·
Journal of Hepatology
·
1
Show more works
View as search
Works count:
19
Citation count:
389
H-index:
9
I10-index:
9
Year
Topic
Type